{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:41:35Z","timestamp":1785796895256,"version":"3.56.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T00:00:00Z","timestamp":1740960000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"The General Program of Anhui Provincial Natural Science Foundation","award":["2308085MH279"],"award-info":[{"award-number":["2308085MH279"]}]},{"name":"The Provincial Financial Support Key program of Anhui Provincial Health Commission","award":["AHWJ2023A10017"],"award-info":[{"award-number":["AHWJ2023A10017"]}]},{"name":"The Key Research and Achievement Transformation program of Wuhu Science and Technology Bureau","award":["2023yf123"],"award-info":[{"award-number":["2023yf123"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Predicting low nuclear grade DCIS before surgery can improve treatment choices and patient care, thereby reducing unnecessary treatment. Due to the high heterogeneity of DCIS and the limitations of biopsies in fully characterizing tumors, current diagnostic methods relying on invasive biopsies face challenges. Here, we developed an ensemble machine learning model to assist in the preoperative diagnosis of low nuclear grade DCIS. We integrated preoperative clinical data, ultrasound images, mammography images, and Radiomic scores from 241 DCIS cases. The ensemble model, based on Elastic Net, Generalized Linear Models with Boosting (glmboost), and Ranger, improved the ability to predict low nuclear grade DCIS preoperatively, achieving an AUC of 0.92 on the validation set, outperforming the model using clinical data alone. The comprehensive model also demonstrated notable enhancements in integrated discrimination improvement and net reclassification improvement (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001). Furthermore, the Radiomic ensemble model effectively stratified DCIS patients by risk based on disease-free survival. Our findings emphasize the importance of integrating Radiomic into DCIS prediction models, offering fresh perspectives for personalized treatment and clinical management of DCIS.<\/jats:p>","DOI":"10.1038\/s41598-025-92080-y","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T17:22:16Z","timestamp":1741022536000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Integrating radiomics into predictive models for low nuclear grade DCIS using machine learning"],"prefix":"10.1038","volume":"15","author":[{"given":"Yimin","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daojing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zongyu","family":"Zha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jieqing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiagui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyang","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pingyang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaoxue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junli","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,3,3]]},"reference":[{"key":"92080_CR1","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.ctrv.2017.03.009","volume":"55","author":"C Mart\u00ednez-P\u00e9rez","year":"2017","unstructured":"Mart\u00ednez-P\u00e9rez, C. et al. Current treatment trends and the need for better predictive tools in the management of ductal carcinoma in situ of the breast. Cancer Treat. Rev. 55, 163\u2013172 (2017).","journal-title":"Cancer Treat. Rev."},{"key":"92080_CR2","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1148\/radiol.2019190762","volume":"292","author":"AM Fowler","year":"2019","unstructured":"Fowler, A. M. Survival outcomes for women with ductal carcinoma in situ in the era of supplemental screening. Radiology 292, 49\u201350 (2019).","journal-title":"Radiology"},{"key":"92080_CR3","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1001\/jamasurg.2015.0876","volume":"150","author":"Y Sagara","year":"2015","unstructured":"Sagara, Y. et al. Survival benefit of breast surgery for low-grade ductal carcinoma in situ. JAMA Surg. 150, 739\u2013745 (2015).","journal-title":"JAMA Surg."},{"key":"92080_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41523-022-00420-2","volume":"8","author":"L Zheng","year":"2022","unstructured":"Zheng, L., G\u00f6kmen-Polar, Y. & Badve, S. S. Is conservative management of ductal carcinoma in situ risky?. npj Breast Cancer 8, 55 (2022).","journal-title":"npj Breast Cancer"},{"key":"92080_CR5","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.ejca.2015.05.008","volume":"51","author":"LE Elshof","year":"2015","unstructured":"Elshof, L. E. et al. Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ \u2013 The LORD study. Eur. J. Cancer 51, 1497\u20131510 (2015).","journal-title":"Eur. J. Cancer"},{"key":"92080_CR6","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10549-023-06934-y","volume":"199","author":"T Ma","year":"2023","unstructured":"Ma, T. et al. Should low-risk DCIS lose the cancer label? An evidence review. Breast Cancer Res. Treat. 199, 415\u2013433 (2023).","journal-title":"Breast Cancer Res. Treat."},{"key":"92080_CR7","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1038\/s41568-022-00512-y","volume":"22","author":"AK Casasent","year":"2022","unstructured":"Casasent, A. K. et al. Learning to distinguish progressive and non-progressive ductal carcinoma in situ. Nat. Rev. Cancer 22, 663\u2013678 (2022).","journal-title":"Nat. Rev. Cancer"},{"key":"92080_CR8","doi-asserted-by":"publisher","first-page":"2036","DOI":"10.3390\/jcm12052036","volume":"12","author":"D Ouattara","year":"2023","unstructured":"Ouattara, D., Mathelin, C., \u00d6zmen, T. & Lodi, M. Molecular signatures in ductal carcinoma in situ (DCIS): A systematic review and meta-analysis. J. Clin. Med. 12, 2036 (2023).","journal-title":"J. Clin. Med."},{"key":"92080_CR9","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s10549-019-05333-6","volume":"177","author":"A Ponti","year":"2019","unstructured":"Ponti, A. et al. Low-grade screen-detected ductal carcinoma in situ progresses more slowly than high-grade lesions: evidence from an international multi-centre study. Breast Cancer Res. Treat. 177, 761\u2013765 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"92080_CR10","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s10549-023-07016-9","volume":"201","author":"H Schandiz","year":"2023","unstructured":"Schandiz, H. et al. Subtypes of high-grade breast ductal carcinoma in situ (DCIS): Incidence and potential clinical impact. Breast Cancer Res. Treat. 201, 329\u2013338 (2023).","journal-title":"Breast Cancer Res. Treat."},{"key":"92080_CR11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.clon.2020.07.007","volume":"33","author":"M Co","year":"2021","unstructured":"Co, M. et al. Long-term survival outcomes of \u2018low risk\u2019 ductal carcinoma in situ from a territory-wide cancer registry. Clin. Oncol. 33, 40\u201345 (2021).","journal-title":"Clin. Oncol."},{"key":"92080_CR12","doi-asserted-by":"publisher","first-page":"e348","DOI":"10.1016\/S1470-2045(13)70135-9","volume":"14","author":"JR Benson","year":"2013","unstructured":"Benson, J. R. & Wishart, G. C. Predictors of recurrence for ductal carcinoma in situ after breast-conserving surgery. Lancet Oncol. 14, e348\u2013e357 (2013).","journal-title":"Lancet Oncol."},{"key":"92080_CR13","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/s41379-019-0204-1","volume":"32","author":"WM Hanna","year":"2019","unstructured":"Hanna, W. M. et al. Ductal carcinoma in situ of the breast: an update for the pathologist in the era of individualized risk assessment and tailored therapies. Modern Pathol. 32, 896\u2013915 (2019).","journal-title":"Modern Pathol."},{"key":"92080_CR14","doi-asserted-by":"publisher","first-page":"2296","DOI":"10.1016\/j.ejca.2015.07.017","volume":"51","author":"A Francis","year":"2015","unstructured":"Francis, A. et al. Addressing overtreatment of screen detected DCIS; The LORIS trial. Eur. J. Cancer 51, 2296\u20132303 (2015).","journal-title":"Eur. J. Cancer"},{"key":"92080_CR15","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-026797","volume":"9","author":"ES Hwang","year":"2019","unstructured":"Hwang, E. S. et al. The COMET (Comparison of Operative versus Monitoring and Endocrine Therapy) trial: A phase III randomised controlled clinical trial for low-risk ductal carcinoma in situ (DCIS). BMJ Open 9, e026797 (2019).","journal-title":"BMJ Open"},{"key":"92080_CR16","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1038\/s41416-018-0276-6","volume":"119","author":"CJC Meurs","year":"2018","unstructured":"Meurs, C. J. C. et al. A prediction model for underestimation of invasive breast cancer after a biopsy diagnosis of ductal carcinoma in situ: Based on 2892 biopsies and 589 invasive cancers. Br. J. Cancer 119, 1155\u20131162 (2018).","journal-title":"Br. J. Cancer"},{"key":"92080_CR17","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1148\/radiol.211425","volume":"303","author":"SE Lee","year":"2022","unstructured":"Lee, S. E. et al. US, mammography, and histopathologic evaluation to identify low nuclear grade ductal carcinoma in situ. Radiology 303, 276\u2013284 (2022).","journal-title":"Radiology"},{"key":"92080_CR18","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1016\/j.ejrad.2013.05.002","volume":"82","author":"A Baur","year":"2013","unstructured":"Baur, A. et al. Breast MRI of pure ductal carcinoma in situ: Sensitivity of diagnosis and influence of lesion characteristics. Eur. J. Radiol. 82, 1731\u20131737 (2013).","journal-title":"Eur. J. Radiol."},{"key":"92080_CR19","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1007\/s10549-013-2598-7","volume":"139","author":"GM Rauch","year":"2013","unstructured":"Rauch, G. M. et al. Clinicopathologic, mammographic, and sonographic features in 1,187 patients with pure ductal carcinoma in situ of the breast by estrogen receptor status. Breast Cancer Res. Treat. 139, 639\u2013647 (2013).","journal-title":"Breast Cancer Res. Treat."},{"key":"92080_CR20","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejrad.2004.11.019","volume":"54","author":"B Barreau","year":"2005","unstructured":"Barreau, B. et al. Mammography of ductal carcinoma in situ of the breast: Review of 909 cases with radiographic\u2013pathologic correlations. Eur. J. Radiol. 54, 55\u201361 (2005).","journal-title":"Eur. J. Radiol."},{"key":"92080_CR21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.21037\/gs-20-428","volume":"9","author":"JK Li","year":"2020","unstructured":"Li, J. K. et al. Ultrasonographic features of ductal carcinoma in situ: Analysis of 219 lesions. Gland Surg. 9, 1945\u20131954 (2020).","journal-title":"Gland Surg."},{"key":"92080_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1007\/s12282-016-0739-7","volume":"24","author":"X Su","year":"2016","unstructured":"Su, X. et al. Non-calcified ductal carcinoma in situ of the breast: Comparison of diagnostic accuracy of digital breast tomosynthesis, digital mammography, and ultrasonography. Breast Cancer 24, 562\u2013570 (2016).","journal-title":"Breast Cancer"},{"key":"92080_CR23","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.clinimag.2015.06.006","volume":"39","author":"MY Kim","year":"2015","unstructured":"Kim, M. Y. et al. Screening mammography-detected ductal carcinoma in situ: Mammographic features based on breast cancer subtypes. Clin. Imaging 39, 983\u2013986 (2015).","journal-title":"Clin. Imaging"},{"key":"92080_CR24","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1016\/j.jhep.2019.02.023","volume":"70","author":"X Xu","year":"2019","unstructured":"Xu, X. et al. Radiomic analysis of contrast-enhanced CT predicts microvascular invasion and outcome in hepatocellular carcinoma. J. Hepatol. 70, 1133\u20131144 (2019).","journal-title":"J. Hepatol."},{"key":"92080_CR25","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1093\/brain\/awab340","volume":"145","author":"G Li","year":"2022","unstructured":"Li, G. et al. An MRI Radiomic approach to predict survival and tumour-infiltrating macrophages in gliomas. Brain 145, 1151\u20131161 (2022).","journal-title":"Brain"},{"key":"92080_CR26","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1016\/j.joca.2022.10.014","volume":"31","author":"T Lin","year":"2023","unstructured":"Lin, T. et al. Prediction of knee pain improvement over two years for knee osteoarthritis using a dynamic nomogram based on MRI-derived Radiomic: a proof-of-concept study. Osteoarthr. Cartilage 31, 267\u2013278 (2023).","journal-title":"Osteoarthr. Cartilage"},{"key":"92080_CR27","doi-asserted-by":"publisher","first-page":"eadf0837","DOI":"10.1126\/sciadv.adf0837","volume":"9","author":"G-H Su","year":"2023","unstructured":"Su, G.-H. et al. Radiogenomic-based multiomic analysis reveals imaging intratumor heterogeneity phenotypes and therapeutic targets. Sci. Adv. 9, eadf0837 (2023).","journal-title":"Sci. Adv."},{"key":"92080_CR28","doi-asserted-by":"publisher","first-page":"516","DOI":"10.21037\/gs-23-417","volume":"13","author":"M Zhu","year":"2024","unstructured":"Zhu, M. et al. Ultrasound deep learning Radiomic and clinical machine learning models to predict low nuclear grade, ER, PR, and HER2 receptor status in pure ductal carcinoma in situ. Gland Surg. 13, 516\u2013531 (2024).","journal-title":"Gland Surg."},{"key":"92080_CR29","doi-asserted-by":"publisher","first-page":"1748","DOI":"10.1002\/jmri.25712","volume":"46","author":"SHS Chou","year":"2017","unstructured":"Chou, S. H. S., Gombos, E. C., Chikarmane, S. A., Giess, C. S. & Jayender, J. Computer-aided heterogeneity analysis in breast MR imaging assessment of ductal carcinoma in situ: Correlating histologic grade and receptor status. J. Magne. Resonance Imaging 46, 1748\u20131759 (2017).","journal-title":"J. Magne. Resonance Imaging"},{"key":"92080_CR30","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jcm.2016.02.012","volume":"15","author":"TK Koo","year":"2016","unstructured":"Koo, T. K. & Li, M. Y. A guideline of selecting and reporting intraclass correlation coefficients for reliability research. J. Chiropractic Med. 15, 155\u2013163 (2016).","journal-title":"J. Chiropractic Med."},{"key":"92080_CR31","doi-asserted-by":"publisher","first-page":"9317","DOI":"10.1007\/s00432-023-04859-z","volume":"149","author":"M Xu","year":"2023","unstructured":"Xu, M. et al. Radiomic nomogram based on digital breast tomosynthesis: Preoperative evaluation of axillary lymph node metastasis in breast carcinoma. J. Cancer Res. Clin. Oncol. 149, 9317\u20139328 (2023).","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"92080_CR32","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1007\/s11547-023-01739-x","volume":"129","author":"M Xu","year":"2023","unstructured":"Xu, M., Zeng, S., Li, F. & Liu, G. Utilizing grayscale ultrasound-based Radiomic nomogram for preoperative identification of triple negative breast cancer. La radiologia medica 129, 29\u201337 (2023).","journal-title":"La radiologia medica"},{"key":"92080_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13058-022-01516-0","volume":"24","author":"X Wang","year":"2022","unstructured":"Wang, X. et al. Radiomic predicts the prognosis of patients with locally advanced breast cancer by reflecting the heterogeneity of tumor cells and the tumor microenvironment. Breast Cancer Res. 24, 20 (2022).","journal-title":"Breast Cancer Res."},{"key":"92080_CR34","doi-asserted-by":"publisher","first-page":"6756","DOI":"10.1038\/s41467-023-41820-7","volume":"14","author":"M Crispin-Ortuzar","year":"2023","unstructured":"Crispin-Ortuzar, M. et al. Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer. Nat. Commun. 14, 6756 (2023).","journal-title":"Nat. Commun."},{"key":"92080_CR35","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1038\/s41416-021-01662-w","volume":"126","author":"C Fotopoulou","year":"2021","unstructured":"Fotopoulou, C. et al. Validation analysis of the novel imaging-based prognostic radiomic signature in patients undergoing primary surgery for advanced high-grade serous ovarian cancer (HGSOC). Br. J. Cancer 126, 1047\u20131054 (2021).","journal-title":"Br. J. Cancer"},{"key":"92080_CR36","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s12282-019-01028-4","volume":"27","author":"BK Killelea","year":"2019","unstructured":"Killelea, B. K. et al. Income disparities in needle biopsy patients prior to breast cancer surgery across physician peer groups. Breast Cancer 27, 381\u2013388 (2019).","journal-title":"Breast Cancer"},{"key":"92080_CR37","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jhqr.2019.02.007","volume":"34","author":"C Natal","year":"2019","unstructured":"Natal, C. et al. Dissemination of health technologies: Trends in the use of diagnostic test in breast cancer screening. J. Healthc. Quality Res. 34, 177\u2013184 (2019).","journal-title":"J. Healthc. Quality Res."},{"key":"92080_CR38","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1080\/02841860802001442","volume":"47","author":"K Hukkinen","year":"2009","unstructured":"Hukkinen, K., Kivisaari, L., Heikkil\u00e4, P. S., Von Smitten, K. & Leidenius, M. Unsuccessful preoperative biopsies, fine needle aspiration cytology or core needle biopsy, lead to increased costs in the diagnostic workup in breast cancer. Acta Oncol. 47, 1037\u20131045 (2009).","journal-title":"Acta Oncol."},{"key":"92080_CR39","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.21037\/gs-23-132","volume":"12","author":"M-R Zhao","year":"2023","unstructured":"Zhao, M.-R. et al. Feasibility analysis of magnetic resonance imaging-based Radiomic features for preoperative prediction of nuclear grading of ductal carcinoma in situ. Gland Surg. 12, 1209\u20131223 (2023).","journal-title":"Gland Surg."},{"key":"92080_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmpb.2024.108039","volume":"245","author":"HJY Wu","year":"2024","unstructured":"Wu, H. J. Y. et al. Sonography-based multimodal information platform for identifying the surgical pathology of ductal carcinoma in situ. Comput. Methods Programs Biomed 245, 108039 (2024).","journal-title":"Comput. Methods Programs Biomed"},{"key":"92080_CR41","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/s43018-022-00388-9","volume":"3","author":"KM Boehm","year":"2022","unstructured":"Boehm, K. M. et al. Multimodal data integration using machine learning improves risk stratification of high-grade serous ovarian cancer. Nat. Cancer 3, 723\u2013733 (2022).","journal-title":"Nat. Cancer"},{"key":"92080_CR42","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1007\/s11547-022-01494-5","volume":"127","author":"D Cozzi","year":"2022","unstructured":"Cozzi, D. et al. Radiomic in pulmonary neuroendocrine tumours (NETs). Radiol. Med. 127, 609\u2013615 (2022).","journal-title":"Radiol. Med."},{"key":"92080_CR43","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41523-017-0045-3","volume":"3","author":"VS Parekh","year":"2017","unstructured":"Parekh, V. S. & Jacobs, M. A. Integrated radiomic framework for breast cancer and tumor biology using advanced machine learning and multiparametric MRI. npj Breast Cancer 3, 43 (2017).","journal-title":"npj Breast Cancer"},{"key":"92080_CR44","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.3390\/cancers15092459","volume":"15","author":"L Brocki","year":"2023","unstructured":"Brocki, L. & Chung, N. C. Integration of radiomic and tumor biomarkers in interpretable machine learning models. Cancers 15, 2459 (2023).","journal-title":"Cancers"},{"key":"92080_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.eswa.2024.123557","volume":"249","author":"F Prinzi","year":"2024","unstructured":"Prinzi, F., Orlando, A., Gaglio, S. & Vitabile, S. Breast cancer classification through multivariate radiomic time series analysis in DCE-MRI sequences. Expert Syst. Appl. 249, 123557 (2024).","journal-title":"Expert Syst. Appl."},{"key":"92080_CR46","doi-asserted-by":"publisher","first-page":"362","DOI":"10.3390\/diagnostics13030362","volume":"13","author":"T He","year":"2023","unstructured":"He, T. et al. 5G-Based telerobotic ultrasound system improves access to breast examination in rural and remote areas: A prospective and two-scenario study. Diagnostics (Basel) 13, 362 (2023).","journal-title":"Diagnostics (Basel)"},{"key":"92080_CR47","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.crad.2019.10.009","volume":"75","author":"DS Gunawardena","year":"2020","unstructured":"Gunawardena, D. S., Burrows, S. & Taylor, D. B. Non-mass versus mass-like ultrasound patterns in ductal carcinoma in situ: Is there an association with high-risk histology?. Clin. Radiol. 75, 140\u2013147 (2020).","journal-title":"Clin. Radiol."},{"key":"92080_CR48","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s11548-018-1900-x","volume":"14","author":"J Li","year":"2018","unstructured":"Li, J. et al. Predicting underestimation of ductal carcinoma in situ: A comparison between radiomic and conventional approaches. Int. J. Comput. Ass. Radiol. Surg. 14, 709\u2013721 (2018).","journal-title":"Int. J. Comput. Ass. Radiol. Surg."},{"key":"92080_CR49","doi-asserted-by":"publisher","first-page":"878","DOI":"10.2214\/AJR.13.12221","volume":"204","author":"ME Scoggins","year":"2015","unstructured":"Scoggins, M. E. et al. Correlation between sonographic findings and clinicopathologic and biologic features of pure ductal carcinoma in situ in 691 patients. AJR Am. J. Roentgenol. 204, 878\u2013888 (2015).","journal-title":"AJR Am. J. Roentgenol."},{"key":"92080_CR50","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s41523-021-00364-z","volume":"8","author":"KW Park","year":"2022","unstructured":"Park, K. W. et al. Ductal carcinoma in situ: a risk prediction model for the underestimation of invasive breast cancer. npj Breast Cancer 8, 8 (2022).","journal-title":"npj Breast Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92080-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92080-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T18:10:21Z","timestamp":1741025421000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-92080-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,3]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["92080"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-92080-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,3]]},"assertion":[{"value":"21 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7505"}}